Background/Aims: Asian Americans have been underrepresented in cancer research. The purpose of this study was to evaluate the efficacy of a multiple arm recruitment approach in improving Asian recruitment into the Cancer Genetics Network (CGN). Methods: 1,096 potential participants, identified through cancer registries located at University of California, Irvine (UCI) and Fred Hutchinson Cancer Research Center (FHCRC), were randomly assigned to receive one of four recruitment approaches. Results: A 6.2% gain in Asian participation into the CGN was achieved over a 2-year period at FHCRC and UCI, which contributed a 2% CGN-wide increase in overall Asian enrollment. Site-specific differences in recruitment success by study arm were observed. Conclusion: Novel recruitment approaches can assist in improving recruitment of Asian populations into cancer genetic research studies.

Hughes C, Peterson SK, Ramirez A, Gallion KJ, McDonald PG, Skinner CS, Bowen D: Minority recruitment in hereditary breast cancer research. Cancer Epidemiol Biomarkers Prev 2004;13:1146–1155.
Kagawa-Singer M: Improving the validity and generalizability of studies with underserved U.S. populations: expanding the research paradigm. Ann Epidemiol 2000;10(8 suppl):92–103.
Paterniti DA, Chen MS Jr, Chiechi C, Beckett LA, Horan N, Turrell C, Smith L, Morain C, Montell L, Luis Gonzalez J, Davis S, Lara PN Jr: Asian Americans and cancer clinical trials: a mixed-methods approach to understanding awareness and experience. Cancer 2005;104(suppl 12):3015–3024.
Tu SP, Chen H, Chen A, Lim J, May S, Drescher C: Clinical trials: understanding and perceptions of female Chinese-American cancer patients. Cancer 2005;104(suppl 12):2999–3005.
Nguyen TT, Somkin CP, Ma Y: Participation of Asian American women in cancer chemoprevention research: physician perspectives. Cancer 2005;104(suppl 12):3006–3014.
Nguyen TT, Somkin CP, Ma Y, Fung L-C, Nguyen T: Participation of Asian-American women in cancer treatment research: a pilot study. J Natl Cancer Inst Monogr 2005;35:102–105.
Hussain-Gambles M, Leese B, Atkin K, Brown J, Mason S, Tovey P: Involving South Asian patients in clinical trials. Health Technol Assess 2004;8:1–109. Review.
Liang W, Yuan E, Mandelblatt JS, Pasick RJ: How do older Chinese women view health and cancer screening? Results from focus groups and implications for interventions. Ethn Health 2004;9:283–304.
Maxwell AE, Bastani R, Vida P, Warda US: Strategies to recruit and retain older Filipino-American immigrants for a cancer screening study. J Community Health 2005;30:167–179.
Kwok C, Sullivan G: Chinese-Australian women’s beliefs about cancer: implications for health promotion. Cancer Nurs 2006;29:E14–21.
Kwok C, Sullivan G: Influence of traditional Chinese beliefs on cancer screening behaviour among Chinese-Australian women. J Adv Nurs 2006;54:691–699.
Anton-Culver H, Ziogas A, Bowen D, Finkelstein D, Griffin C, Hanson J, Isaacs C, Kasten-Sportes C, Mineau G, Nadkarni P, Rimer B, Schildkraut J, Strong L, Weber B, Winn D, Hiatt R, Nayfield S: The Cancer Genetics Network: recruitment results and pilot studies. Community Genet 2003;6:171–177.
Groves RM, Couper MP: Nonresponse in Household Interview Surveys. New York, John Wiley & Sons, 1998.
Dillman DA: Mail and Telephone Surveys: The Total Design Method. New York, Wiley, 1978.
Goyder J: The Silent Minority: Nonrespondents on Sample Surveys. Boulder, Westview, 1987.
Schulz KF, Chalmers I, Hayes RJ, Altman DG: Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408–412.
The SAS System for Windows (version 8). Cary, SAS Institute, Inc, 1999.
Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D: The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134:663–694.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.